Design Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:DSGN) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 9.55 M9.86 M16.79 M14.44 M11.16 M 52.25 M Cash from investing activities -5.83 M1.83 M7.87 M20.12 M6.51 M 36.33 M Cash from financing activities 1 000263 K23 K361 K37 K 684 K Free cash flow 9.56 M9.86 M16.72 M14.35 M11.16 M 52.09 M

Notizie

Oppenheimer promuove il titolo Compass Pathways a Outperform grazie al percorso FDA

Craig-Hallum avvia copertura su Design Therapeutics con rating Buy

Craig-Hallum initiates Design Therapeutics stock with Buy rating

Leerink Partners promuove Design Therapeutics a Outperform grazie ai progressi del pipeline

Leerink Partners upgrades Design Therapeutics stock to Outperform on pipeline progress

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday - Cipher Mining (NASDAQ:CIFR), Aduro Clean Technologies (NASDAQ:ADUR)

RBC Capital migliora il rating delle azioni Design Therapeutics grazie a prospettive più favorevoli

Design Therapeutics stock rating upgraded by RBC Capital on improved outlook

Design Therapeutics unveils DT-818 for myotonic dystrophy treatment

Design Therapeutics, Inc. (DSGN) Presents at Cantor Global Healthcare Conference 2025 Tran

Steven Cohen’s Biotech Bets Are Getting Bolder - And Smaller - Invivyd (NASDAQ:IVVD)

Design Therapeutics reports voting results from annual meeting